Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 8/2021

01-08-2021 | Endoscopy | Letter to the Editor

A De Novo Gastric Cancer 1 Year After Sleeve Gastrectomy—Is Bariatric Surgery a Risk Factor for Gastroesophageal Cancer Development?

Authors: Khosrow Najjari, Hossein Zabihi Mahmoudabadi, Hamidreza Zand, Mohammad Talebpour

Published in: Obesity Surgery | Issue 8/2021

Login to get access

Excerpt

Bariatric surgeries for the treatment of morbid obesity are increasing. Bariatric surgery reduces the incidence of hormone-related malignancies, such as endometrial, breast, and colon cancers [1]. On the other hand, gastroesophageal cancer after bariatric surgery has been rarely reported over the last few years, even though obesity is one of the risk factors for gastric cancer [2]. In particular, gastric cancer after SG has only been reported a few times so far [3‐13]. …
Literature
1.
Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.CrossRef
2.
Renehan AG, Soerjomataram I, Leitzmann MF. Interpreting the epidemiological evidence linking obesity and cancer: a framework for population-attributable risk estimations in Europe. Eur J Cancer. 2010;46:2581–92.CrossRef
3.
Scheepers AF, Schoon EJ, Nienhuijs SW. Esophageal carcinoma after sleeve gastrectomy. Surg Obes Relat Dis. 2011;7(4):e11–2.CrossRef
4.
Angrisani L, Santonicola A, Iovino P. Gastric cancer: a de novo diagnosis after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(1):186–7.CrossRef
5.
Erim T, Colak Y, Szomstein S. Gastric carcinoid tumor after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2015;11(6):e51–2.CrossRef
6.
Masrur M, Elli E, Gonzalez-Ciccarelli LF, et al. De novo gastric adenocarcinoma 1 year after sleeve gastrectomy in a transplant patient. Int J Surg Case Rep. 2016;20:10–3.CrossRef
7.
Vladimirov M, Hesse U, Stein HJ. Gastric carcinoma after sleeve gastrectomy for obesity. Surg Obes Relat Dis. 2017;13(8):1459–61.CrossRef
8.
El Khoury L, Benvenga R, Romero R, et al. Esophageal adenocarcinoma in Barrett’s esophagus after sleeve gastrectomy: case report and literature review. Int J Surg Case Rep. 2018;52:132–6.CrossRef
9.
10.
Sohn S, Fischer J, Booth M. Adenocarcinoma of the gastro-oesophageal junction after sleeve gastrectomy: a case report. ANZ J Surg. 2017;87(10):E163–E4.CrossRef
11.
Wright FG, Duro A, Medici JR, et al. Esophageal adenocarcinoma five years after laparoscopic sleeve gastrectomy. A case report. Int J Surg Case Rep. 2017;32:47–50.CrossRef
12.
Seki Y, Kasama K, Tanaka T, et al. Early gastric cancer successfully treated by endoscopic submucosal resection 1 year after laparoscopic sleeve gastrectomy with duodenal-jejunal bypass. Asian J Endosc Surg. 2019;12(3):357–61.CrossRef
13.
Orellana M. Gastric cancer after laparoscopic sleeve gastrectomy: a case report and literature review. 2021;2–5.
14.
Brown WA, Johari Halim Shah Y, Balalis G, et al. IFSO position statement on the role of esophago-gastroduodenal endoscopy prior to and after bariatric and metabolic surgery procedures. Obes Surg. 2020;30(8):3135–53.CrossRef
15.
Qumseya BJ, Qumsiyeh Y, Ponniah SA, et al. Barrett’s esophagus: a systematic review and meta-analysis. Gastrointest Endosc. 2021;93(2):343–52. e2CrossRef
16.
Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia-cancer sequence. Nat Rev Cancer. 2017;17(10):594–604. after sleeve gastrectomyCrossRef
17.
Orlando G, Pilone V, Vitiello A, et al. Gastric cancer following bariatric surgery: a review. Surg Laparosc Endosc Percutan Tech. 2014;24(5):400–5.CrossRef
Metadata
Title
A De Novo Gastric Cancer 1 Year After Sleeve Gastrectomy—Is Bariatric Surgery a Risk Factor for Gastroesophageal Cancer Development?
Authors
Khosrow Najjari
Hossein Zabihi Mahmoudabadi
Hamidreza Zand
Mohammad Talebpour
Publication date
01-08-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 8/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-021-05410-0

Other articles of this Issue 8/2021

Obesity Surgery 8/2021 Go to the issue

Original Contributions

Fifteen Years After Sleeve Gastrectomy: Weight Loss, Remission of Associated Medical Problems, Quality of Life, and Conversions to Roux-en-Y Gastric Bypass—Long-Term Follow-Up in a Multicenter Study

Review

What Is Weight Loss After Bariatric Surgery Expressed in Percentage Total Weight Loss (%TWL)? A Systematic Review

Letter to the Editor

First Case of Laparoscopic-Endoscopic Management of a Rare Complication After Roux-en-Y Gastric Bypass: Bleeding Dieulafoy’s Lesion in the Excluded Duodenal Tract

Brief Communication

Time of Bariatric Surgery and Hospitalization for SARS-CoV-2: a Nationwide Study

Original Contributions

Long-Term Results of One Anastomosis Gastric Bypass: a Single Center Experience with a Minimum Follow-Up of 10 Years

Original Contributions

Roux-en-Y Gastric Bypass with Long Biliopancreatic Limb Compared to Single Anastomosis Sleeve Ileal (SASI) Bypass in Treatment of Morbid Obesity